Online test nails early Alzheimer's diagnosis with biomarker precision
In a recent study posted to the medRxiv preprint* server, researchers evaluated the use of the Oxford Cognitive Testing Portal's (OCTAL) digital cognitive testing platform for Alzheimer's disease (AD) patients and correlated their findings with serological biomarkers of AD. AD research faces a significant limitation in measuring cognitive performance robustly, remotely, and frequently. There are no established online digital platforms […]
Continue reading »